Patent details

Basic Information

Publication number:

EP2191824

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP091722850

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Modified release 1-Ö(3-hydroxy-adamant-1-ylamino)-acetylÜ-pyrrolidine-2(s)-carbonitrile formulation

French Title of Invention:

Formulation de 1-Ö(3-hydroxy-adamant-1-ylamino)-acetylÜ-pyrrolidine-2(s)-carbonitrile à libération modifiée

German Title of Invention:

1-Ö(3-Hydroxy-Adamant-1-Ylamino)-AcetylÜ-Pyrrolidin-2(s)-Carbonitril-Formulierung mit modifizierter Freisetzung

SPC Number:

Dates

Filing date:

08/06/2006

Grant date:

14/03/2012

EP Publication Date:

14/03/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/06/2010

EP B1 Publication Date:

14/03/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/06/2012

Expiration date:

08/06/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/06/2006

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

Joshi Yatindra

Address:

United States (US)

2

Name:

Serajuddin Abu, T. M.

Address:

United States (US)

3

Name:

Lakshman Jay, Parthiban

Address:

United States (US)

4

Name:

Kowalski James

Address:

United States (US)

Priority

1

Priority Number:

689719 P

Priority Date:

10/06/2005

Priority Country:

United States (US)

2

Priority Number:

690309 P

Priority Date:

14/06/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/40;

Filing date	Document type	Number of pages